LinkedIn Icon
April 22-25, 2019 | Boston, MA


ProSciento is a full scope clinical R&D services provider, exclusively focused on diabetes, NASH and obesity. The company is widely recognized for quality and scientific excellence, an unparalleled methodological toolkit, and extensive experience with virtually all relevant metabolic drug and device classes. Through its scalable R&D services model – combining deep therapeutic area expertise, strategic planning, and operational execution from preclinical to phase III readiness – ProSciento provides highly customized services for its global client base.